DeepLook Medical Wins Top Prize at Venture Madness 2026
DeepLook Medical has received top honors at the 2026 Venture Madness pitch competition, announced in a press release. The company develops AI imaging software for early cancer detection and has been expanding its operations in Arizona with the support of Xcellerant Ventures.
DeepLook’s FDA cleared software, DL Precise, provides radiologists with one click tumor segmentation and morphological displays. The software uses AI shape recognition to define tumor boundaries, particularly in dense breast tissue, to support early diagnosis.
Since relocating to Arizona, DeepLook has integrated into the local healthcare network and scaled its clinical operations, including collaborations with Banner MD Anderson. The hospital will serve as lead researcher for an upcoming breast surgery trial. Xcellerant Ventures’ first investment in women’s health supported DeepLook’s growth and connection to Arizona’s life sciences ecosystem.
The Venture Madness award, supported by the Arizona Innovation Challenge, marks a milestone for DeepLook’s expansion in the region and its continued focus on women’s health imaging technologies.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
DeepSeek Reportedly Agrees to Lead Winverse AI Seed Round
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Likang to Present AI Cancer Immunotherapy Platform in Abu Dhabi
Healthleap Raises $38 Million for Hospital Risk Screening AI
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Daily AI Brief: the AI news that matters, in your inbox.